Effects of soy phytoestrogens genistein and daidzein on breast cancer growth

ML De Lemos - Annals of Pharmacotherapy, 2001 - journals.sagepub.com
… Genistein and Daidzein on Breast Cancer Growth - Mário L de Lemos, 2001 … chez l'animal
et antagonisent l'effet antitumoral du tamoxifène in vitro. A fortes concentrations (plus de 10 μM…

Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies

ML de Lemos, T Hsieh, L Hamata, A Levin… - Gynecologic …, 2006 - Elsevier
OBJECTIVES.: Carboplatin dosing is usually based on glomerular filtration rate (GFR). The
Cockcroft–Gault and the Modified Diet in Renal Disease (MDRD) Study formulae are based …

Interaction between mercaptopurine and milk

ML de Lemos, L Hamata… - Journal of Oncology …, 2007 - journals.sagepub.com
Mercaptopurine is a purine analog used for acute lymphoblatic leukemia and chronic
myelogenous leukemias. Since it is inactivated by xanthine oxidase (XO), concurrent intake of …

Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis

ML de Lemos, I Kang, K Schaff - Journal of Oncology …, 2019 - journals.sagepub.com
Background Patients with locally advanced, recurrent or metastatic solitary fibrous tumour
are often treated with bevacizumab and temozolomide based on the clinical efficacy reported …

Management of extravasation of oxaliplatin

ML de Lemos, S Walisser - Journal of Oncology Pharmacy …, 2005 - journals.sagepub.com
Oxaliplatin extravasation has been associated with local pain and inflammation which may
be severe and lead to complications including necrosis. Recent case reports suggest that …

Clinical efficacy of generic imatinib

ML de Lemos, V Kyritsis - Journal of Oncology Pharmacy …, 2015 - journals.sagepub.com
Background Generic imatinib has recently been approved for chronic myeloid leukemia in
Canada and the European Union (EU). There are anecdotal concerns of reduced efficacy …

Leaching of diethylhexyl phthalate from polyvinyl chloride materials into etoposide intravenous solutions

ML de Lemos, L Hamata, T Vu - Journal of Oncology …, 2005 - journals.sagepub.com
Etoposide intravenous solution is associated with leaching of diethylhexyl phthalate (DEHP)
from bags and tubings made from polyvinyl chloride (PVC). Recent evidence suggests that …

Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: a population-based evaluation

ML de Lemos, A Markarian, E Chan… - Journal of Oncology …, 2018 - journals.sagepub.com
Background Bevacizumab is an antiangiogenic agent active in patients with recurrent
malignant gliomas. However, evidence for its clinical efficacy is relatively limited so that …

Efficacy of nivolumab four-weekly dosing schedule based on body weight

ML de Lemos, C Kung… - Journal of Oncology …, 2019 - journals.sagepub.com
Nivolumab has received regulatory approval to be given by weight-based or flat dosing
every two weeks or by flat dosing every four weeks. However, flat dosing would lead to …

Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin

S Jennings, ML De Lemos, A Levin… - Journal of Oncology …, 2010 - journals.sagepub.com
Background. Glomerular filtration rate (GFR) is often used to determine initial dosing of
renally excreted cancer drugs. GFR can be calculated using the Cockcroft-Gault (CG) or the …